NDC 80425-0016-04 - Cyclobenzaprine HCL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0016
- Requested NDC
- 80425-0016-04
- Package NDCs from labels
- 80425-0016-4, 80425-0016-2, 80425-0016-1, 80425-0016-3, 80425-0016-04
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cyclobenzaprine HCL - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0016-1 | Cyclobenzaprine HCL | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 9 | |
| 80425-0016-2 | Cyclobenzaprine HCL | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 9 | |
| 80425-0016-3 | Cyclobenzaprine HCL | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 9 | |
| 80425-0016-4 | Cyclobenzaprine HCL | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0016 | CYCLOBENZAPRINE HCL TABLET, FILM COATED [ADVANCED RX OF TENNESSEE, LLC] | 9 | Current NDC, Legacy NDC, 4 package rows | 20250101_afca1267-4d8f-7453-e053-2995a90a865c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0016-1 | EA - Each | 80425-0016 | 553b5f4f-98c3-412b-becd-97fa84f94451 | 1 | 2023-03-13 |
| 80425-0016-2 | EA - Each | 80425-0016 | fe471193-8819-43eb-88db-2bc0724a7bd3 | 1 | 2023-03-13 |
| 80425-0016-3 | EA - Each | 80425-0016 | 820b6eaa-987b-4e93-815e-c755aa14355b | 1 | 2023-03-13 |
| 80425-0016-4 | EA - Each | 80425-0016 | 916a100b-1077-409a-8f91-67bd1ab8d97b | 1 | 2023-03-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | 85128989-bfa3-4b82-94c1-f90b14ccd2f9 | 2026-11-09 | Warnings, Adverse reactions | ANDA208170 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e505c31b-4618-4e4f-8da6-92030464004f | 2026-11-06 | Warnings, Adverse reactions | 828320 0VE05JYS2P |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | REMEDYREPACK INC. | 51d85ea8-8317-4a76-a108-20383f118ad4 | 2026-11-05 | Warnings, Adverse reactions | 828348 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Bryant Ranch Prepack | d2976864-0427-40f3-bad8-6f7646ea0d57 | 2026-11-03 | Warnings, Adverse reactions | 828299 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE | American Health Packaging | 269bc278-963d-4830-816a-39bb4bf8c936 | 2026-10-29 | Warnings, Adverse reactions | 828348 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | REMEDYREPACK INC. | 84c306bf-f34d-4cd6-ae22-5f6488cb3153 | 2026-10-28 | Warnings, Adverse reactions | 828348 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3baeda95-d098-437a-b360-87a9c3f3fd9b | 2026-10-15 | Warnings, Adverse reactions | 828320 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 59b428fa-5013-4b2b-872f-16ba4a9d4f5d | 2026-10-15 | Warnings, Adverse reactions | 828320 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 4ee4feec-4590-fa7f-e063-6394a90a5550 | 2026-10-15 | Warnings, Adverse reactions | ANDA208170 828348 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9161cb5e-63e5-41d7-9bde-66c7b7b7a2f3 | 2026-10-15 | Warnings, Adverse reactions | 828348 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | AiPing Pharmaceutical, Inc. | 17a212c9-1708-48e2-b755-3a75e92cbb59 | 2026-10-15 | Warnings, Adverse reactions | 828299 828320 828348 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3aaa4808-7f2d-410c-9b6c-193549ec0845 | 2026-10-14 | Warnings, Adverse reactions | 828348 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 7829a96a-3668-4d88-90e9-0ecbedb2bd7e | 2026-10-14 | Warnings, Adverse reactions | 828348 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | 550d3e5a-c95f-4094-a500-1a02ea35a18d | 2026-10-09 | Warnings, Adverse reactions | 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Coral Way Pharma LLC | 5d0d6eec-28e8-6fca-e063-6294a90a59cd | 2026-10-07 | Warnings, Adverse reactions | ANDA208170 828299 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | NuCare Pharmaceutuicals,Inc. | 7c732db1-8321-82a4-e053-2991aa0aa8a0 | 2026-10-07 | Warnings, Adverse reactions | ANDA208170 828320 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | SA3, LLC | a4ae481f-9e47-470a-b4d1-5a33c0df8761 | 2026-09-28 | Warnings, Adverse reactions | 828299 0VE05JYS2P |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | A-S Medication Solutions | f2286776-a7de-42dc-b745-d250e741eeb6 | 2026-09-23 | Warnings, Adverse reactions | 828320 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | HAWAII REPACK, INC. | cf5d4de9-79c3-4935-be69-89e98d7b54cc | 2026-09-15 | Warnings, Adverse reactions | ANDA208170 828299 828320 828348 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | REMEDYREPACK INC. | 12454c61-8782-43d5-8426-9e79232b68ae | 2026-09-14 | Warnings, Adverse reactions | ANDA208170 828299 0VE05JYS2P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.